Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2002;57:189-190; doi:10.1136/thorax.57.3.189
Copyright © 2002 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 2002;57:189-190
© 2002 Thorax

EDITORIAL

Cystic fibrosis

Macrolide antibiotics and cystic fibrosis

D G Peckham

Regional Adult CF Unit, Seacroft Hospital, Leeds LS14 6UH, UK

Correspondence to:
Correspondence to:
Dr D Peckham, Regional Adult CF Unit, Seacroft Hospital, Leeds LS14 6UH, UK


Do the macrolides have a role in the treatment of cystic fibrosis?

Keywords: cystic fibrosis; macrolide antibiotics; azithromycin

There is growing interest in the potential use of macrolide antibiotics as anti-inflammatory agents in cystic fibrosis. This stems from the dramatic success of long term erythromycin in the treatment of diffuse panbronchiolitis (DPB), a condition with a high prevalence in Japan but rare elsewhere.1–3 Clinically, DPB exhibits some similarities to cystic fibrosis including chronic productive cough, exertional dyspnoea, chronic sinusitis, mucoid Pseudomonas aeruginosa colonisation, and bronchiectasis. The introduction of erythromycin as a treatment for DPB has had a dramatic impact on mortality, increasing 10 year survival from 12.4–21.9% to over 90% in those colonised with P aeruginosa.3,4 Similar success has been reported with clarithromycin, roxithromycin, and azithromycin.1,3 While the aetiology of both conditions may be very different, it is the similarities which beg the question "do the macrolides have a role in the treatment of cystic fibrosis?"

The macrolide antibiotics are an intriguing group of drugs . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., Wedzicha, J. A. (2008). Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations. Am. J. Respir. Crit. Care Med. 178: 1139-1147 [Abstract] [Full Text]  
  • Rubin, B. K., Henke, M. O. (2004). Immunomodulatory Activity and Effectiveness of Macrolides in Chronic Airway Disease. Chest 125 : 70S-78S [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs